Stenlund Peter, Frostell-Karlsson Asa, Karlsson Olof P
Department of Systems and Applications, Biacore AB, SE-754 50 Uppsala, Sweden.
Anal Biochem. 2006 Jun 15;353(2):217-25. doi: 10.1016/j.ab.2006.03.004. Epub 2006 Mar 20.
Reversible protein phosphorylation of serine, threonine, and tyrosine residues by protein kinases and phosphatases is important for the regulation of cellular signal transduction and controls many cellular functions. Disturbances in this regulation have been implicated in a growing number of diseases, making kinases and phosphatases useful targets for therapeutic intervention. The suitability of surface plasmon resonance (SPR) technology has been widely demonstrated in many drug discovery applications. A novel and straightforward methodology is presented for analyzing small molecule binding to two serine/threonine phosphatases, PP1 and PP2B (calcineurin), and to the prototypic tyrosine phosphatase, PTP1B. Emphasis was placed on investigating the immobilization conditions of the phosphatases by using reducing conditions, inhibitors and metal ions. A comparison of inhibitor binding, either to phosphatase (PP2B) alone or in complex with the regulatory protein subunit calmodulin, revealed different kinetics. The methodology was also used to test inhibitor specificity toward different phosphatases. Inhibition of regulatory protein PP-inhibitor-2 binding to PP1 by a small molecule inhibitor was demonstrated. This type of information, together with data on compound binding that is independent of enzyme activity and in which affinities are resolved into kinetic rate constants, may be of great significance for the development of highly specific and high-affinity phosphatase inhibitors.
蛋白激酶和磷酸酶对丝氨酸、苏氨酸及酪氨酸残基进行的可逆蛋白磷酸化作用,对于细胞信号转导的调控至关重要,并控制着许多细胞功能。这种调控的紊乱与越来越多的疾病有关,使得激酶和磷酸酶成为治疗干预的有用靶点。表面等离子体共振(SPR)技术的适用性在许多药物发现应用中已得到广泛证明。本文提出了一种新颖且直接的方法,用于分析小分子与两种丝氨酸/苏氨酸磷酸酶PP1和PP2B(钙调磷酸酶)以及原型酪氨酸磷酸酶PTP-1B的结合。重点在于通过使用还原条件、抑制剂和金属离子来研究磷酸酶的固定条件。对抑制剂单独与磷酸酶(PP2B)结合或与调节蛋白亚基钙调蛋白形成复合物后的结合情况进行比较,揭示了不同的动力学。该方法还用于测试抑制剂对不同磷酸酶的特异性。证明了一种小分子抑制剂对调节蛋白PP抑制剂-2与PP1结合的抑制作用。这类信息,连同与酶活性无关的化合物结合数据以及将亲和力解析为动力学速率常数的数据,对于开发高特异性和高亲和力的磷酸酶抑制剂可能具有重要意义。